Cargando…

Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy

BACKGROUND: We evaluated the differential impact of levofloxacin administered for the prophylaxis of bloodstream infections compared with broad-spectrum beta-lactam (BSBL) antibiotics used for the treatment of neutropenic fever on the gut microbiome in patients with hematologic malignancy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziegler, Matthew, Han, Jennifer H, Landsburg, Daniel, Pegues, David, Reesey, Emily, Gilmar, Cheryl, Gorman, Theresa, Bink, Kristen, Moore, Amy, Kelly, Brendan J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602896/ https://www.ncbi.nlm.nih.gov/pubmed/31281857 http://dx.doi.org/10.1093/ofid/ofz252

Ejemplares similares

1595. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients with Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2018)

Clinical Characteristics and Outcomes of Hematologic Malignancy Patients with Clostridium difficile Toxin EIA vs. PCR Positive Test Results
por: Ziegler, Matthew, et al.
Publicado: (2017)

Prophylaxis with levofloxacin: bacterial infections and antimicrobial resistance in hematological malignancies
por: Campos, Claudio Penido
Publicado: (2014)

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2013)

194. Antibiotic-resistant bloodstream infections in pediatric oncology patients on levofloxacin prophylaxis
por: Sridhar, Sunita, et al.
Publicado: (2020)

Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients
por: Guimarães, Thaís, et al.
Publicado: (2022)

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
por: Zimmer, Andrea J, et al.
Publicado: (2022)

Limited Positive Predictive Value of β-d-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
por: Chang, Euijin, et al.
Publicado: (2020)

When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients
por: Batchelor, R, et al.
Publicado: (2021)

Low Diversity in Nasal Microbiome Associated With Staphylococcus aureus Colonization and Bloodstream Infections in Hospitalized Neonates
por: Zhao, Ni, et al.
Publicado: (2021)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

1591. Infectious Outcomes of Levofloxacin Prophylaxis in Obese vs. Non-obese Patients with Hematologic Malignancies
por: Kurtti, Amanda, et al.
Publicado: (2018)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

2685. Oral Third-Generation Cephalosporins vs. Levofloxacin for Antibacterial Prophylaxis in Neutropenic Patients with Hematologic Malignancies
por: DeVoe, Catherine, et al.
Publicado: (2019)

Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Fulcher, Jennifer A, et al.
Publicado: (2019)

Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
por: D’Souza, Alaric W, et al.
Publicado: (2019)

Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections
por: Santibañez, Melissa, et al.
Publicado: (2019)

Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial( )
por: Paradkar, Mandar S, et al.
Publicado: (2022)

Precision Identification of Diverse Bloodstream Pathogens in the Gut Microbiome
por: Tamburini, Fiona B., et al.
Publicado: (2018)

Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
por: Sarzynski, Sadia H, et al.
Publicado: (2022)

Impact on Mortality of a Bundle for the Management of Enterococcal Bloodstream Infection
por: Bartoletti, Michele, et al.
Publicado: (2019)

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
por: Clerici, Daniela, et al.
Publicado: (2022)

Infectious Diseases Consultation Is Associated With Decreased Mortality in Enterococcal Bloodstream Infections
por: Lee, Rachael A, et al.
Publicado: (2020)

Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy
por: Linden-Castro, Edgar, et al.
Publicado: (2014)

Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection
por: Montassier, Emmanuel, et al.
Publicado: (2016)

Tracking gut microbiome and bloodstream infection in critically ill adults
por: Gu, Christopher H., et al.
Publicado: (2023)

Clinical and Genomic Characterization of Recurrent Enterococcal Bloodstream Infection in Patients With Acute Leukemia
por: Messina, Julia A, et al.
Publicado: (2018)

Pathogen Species Is Associated With Mortality in Nosocomial Bloodstream Infection in Patients With COVID-19
por: Gago, Juan, et al.
Publicado: (2022)

Management of Bloodstream Infections in Left Ventricular Assist Device Recipients: To Suppress, or Not to Suppress?
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

Bloodstream Infection Following Cardiac Valve Repair: A Population-Based Study
por: McHugh, Jack W, et al.
Publicado: (2021)

Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Staphylococcus aureus Bloodstream Infections
por: Molina, Kyle C, et al.
Publicado: (2022)

Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections
por: Moenster, Ryan P, et al.
Publicado: (2023)

Protection of the Human Gut Microbiome From Antibiotics
por: de Gunzburg, Jean, et al.
Publicado: (2018)

Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2019)

Difference in the Clinical Outcome of Bloodstream Infections Caused by Klebsiella aerogenes and Enterobacter cloacae Complex
por: Jeon, Minji, et al.
Publicado: (2021)

The Impact of Nosocomial Bloodstream Infections on Mortality: A Retrospective Propensity-Matched Cohort Study
por: Petersiel, Neta, et al.
Publicado: (2021)

Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana
por: Harris, Vanessa C., et al.
Publicado: (2017)

SARS-CoV-2 RNA persists on surfaces following terminal disinfection of COVID-19 hospital isolation rooms
por: Zhang, Helen L., et al.
Publicado: (2022)

Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cc3lldcpe2d655nugfut1lp22h